MiMedx Group, Inc
MDXG
Positions held
Your positionsMDXG isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $674.22M | Enterprise value | $554.78M | Trailing P/E | 115.50 | Forward P/E | 23.10 |
| PEG | 2.88 | Price / book | 3.12 | Beta | 1.17 | Dividend yield | 0.00% |
| Revenue growth | -34.7% | Earnings growth | — | Gross margin | 78.8% | Operating margin | -28.7% |
| Profit margin | 1.8% | ROE | 2.9% | ROA | 1.9% | Debt / equity | 0.08 |
| Current ratio | 5.33 | Free cash flow | $41.43M | Analyst recommendation | none | Mean target | $7.40 |
| 52w high | $7.97 | 52w low | $3.03 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $64.4M | $59.0M | $118M | $114M | $98.6M | — |
| Op margin | -28.7% | -27.2% | 17.8% | 19.5% | 12.5% | — |
| Net income | -$14.8M | -$10.9M | $15.2M | $16.7M | $9.6M | — |
| Gross margin | 69.0% | 70.6% | 83.9% | 83.5% | 81.1% | — |
| Gross profit | $44.4M | $41.6M | $99.0M | $95.0M | $79.9M | — |
| Operating income | -$18.5M | -$16.0M | $21.1M | $22.2M | $12.4M | — |
- Revenue +9% vs prior quarter ($64M vs $59M).
- Gross margin 69% (was 70.6% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $419M | $349M | $321M | $268M | — |
| Op margin | 15.3% | 17.0% | 11.5% | -5.5% | — |
| Net income | $48.6M | $42.4M | $58.2M | -$30.2M | — |
| Gross margin | 82.6% | 82.8% | 83.0% | 82.0% | — |
| Gross profit | $346M | $289M | $267M | $220M | — |
| Operating income | $63.9M | $59.3M | $37.1M | -$14.7M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-23 · MiMedx Says it Received Favorable Court Ruling in Axiofill Classification Matter
2026-09-23 · MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter
2026-09-08 · MIMEDX to Participate in Upcoming Investor Conferences
2026-08-08 · MiMedx (MDXG) Q2 2026 Earnings Call Transcript
2026-07-30 · MiMedx Group, Inc. Q2 2026 Earnings Call Summary
2026-07-30 · MiMedx Group Inc (MDXG) (Q2 2026) Earnings Call Highlights: Surgical Growth and Transformative ...
2026-07-29 · MiMedx Group Q2 Earnings Call Highlights
2026-07-29 · MiMedx: Q2 Earnings Snapshot
2026-07-29 · MIMEDX Announces Second Quarter 2026 Operating & Financial Results
2026-07-29 · MIMEDX to Acquire Sanara MedTech
2026-07-28 · Earnings To Watch: MiMedx Group Inc (MDXG) Q2 2026 -- GF Value Sees 35% Upside
2026-07-20 · MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29
Price (daily)
Full chart · RSI · MACD · patterns